Scabies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with confirmed scabies, of both sexes, 19 years or older, who present itching mainly at night and the presence of skin lesions, who agree to participate in the study after signing their informed consent.
Exclusion criteria
Exclusion criteria: Patients with: 1. Skin lesions with added infection 2. Known hypersensitivity to the products to be used 3. Other skin lesions already diagnosed 4. Moderate-severe cognitive disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Cure clinical (absence of itching and skin lesions ) or clinical improvement (improvement of itching and skin lesions). Measurement time: 7, 14 and 21 days of treatment. 2. Negativization of Dermatoscopy (Positive, Negative). Measurement time: 21 days of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. EASI Scale (Eczema Area and Severity Index). Measurement time: At baseline and, 7, 14 and 21 days of treatment. 2. VAS Scale (Visual analogical scale). Measurement time: At baseline and, 7, 14 and 21 days of treatment. 3. Quality of Life Questionnaire (EuroQol). Measurement time: At baseline and, 7, 14 and 21 days of treatment. | — |
Countries
Cuba
Contacts
10 de Octubre Clinical Surgical Teaching Hospital